“Safe Use” to launch in January
Executive Summary
FDA's initiative to influence the safe use of drugs will kick off in the new year, Woodcock said at the DIA/FDA/PhRMA conference. "FDA does not control the health care system, so our improving the use of marketed drugs, to a great extent, is going to involve influence rather than control," by partnering with the growing patient safety movement, she said. "The vast majority of harm from approved drugs comes from misuse, inappropriate use ... failure to use, abuse, [and] medical mix-ups. There is just carnage out there, and we know that." The program was announced in conjunction with the "Safety First" pharmacovigilance initiative (1"The Pink Sheet," March 3, 2008, p. 6)
You may also be interested in...
FDA Faces “Daunting” Mission As It Partners With Doctors For Safe Rx Use
One of FDA's mantras has been that is does not regulate the practice of medicine, and while the agency remains committed to that doctrine, it is now trying to find ways to better influence how doctors prescribe and discuss drugs through its "Safe Use" initiative
Biogen Sees Improving Momentum In Slow Leqembi Launch
Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.
Vivalink Partners With Rett Syndrome Research Trust To Accelerate Research In Rare Disease
Vivalink will provide ECG wearable technology to monitor patients in RSRT’s Vibrant study, which is aimed at assessing autonomic dysfunction in children with Rett syndrome.